scholarly journals Impact of antiplatelet therapy on increased blood loss and bleeding complication in patients undergoing urgent cholecystectomy for acute cholecystitis

HPB ◽  
2019 ◽  
Vol 21 ◽  
pp. S549
Author(s):  
T. Fujikawa ◽  
Y. Yoshimoto ◽  
Y. Kawamura ◽  
T. Nishimura ◽  
H. Kawamoto ◽  
...  
HPB ◽  
2019 ◽  
Vol 21 ◽  
pp. S886
Author(s):  
T. Fujikawa ◽  
Y. Yoshimoto ◽  
Y. Kawamura ◽  
T. Nishimura ◽  
H. Kawamoto ◽  
...  

2017 ◽  
Vol 83 (5) ◽  
pp. 486-490 ◽  
Author(s):  
Keiichi Akahoshi ◽  
Takanori Ochiai ◽  
Ayumi Takaoka ◽  
Takuya Kitamura ◽  
Daisuke Ban ◽  
...  

The use of antiplatelet therapy (APT) and/or anticoagulant therapy (ACT) continues to increase due to the aging population. Because the management of patients with acute cholecystitis receiving APT/ACTis still unclear, surgeons are sometimes faced with the difficult decision to delay surgery. We aimed to analyze characteristics and surgical risks of patients who underwent emergency cholecystectomy for acute cholecystitis without discontinuing APT. We conducted a retrospective review of 113 patients between 2006 and 2014. Treatment outcomes among 13 patients who underwent cholecystectomy without discontinuing APT (the cAPT group), 11 patients who discontinued APT and ACT (the D group), and 89 patients who did not receive preoperative APT and/or ACT (the No APT group) were compared. There were no significant differences in intraoperative blood loss, conversion to open surgery, and bleeding-related complications. However, the incidence of intraoperative blood transfusion was higher in the cAPT group (P = 0.04). They presented with severe local inflammation; thus, it was difficult to stop bleeding from the gallbladder bed. Hemostatic tools for liver surgery were used to control bleeding. Emergency cholecystectomy was tolerable for patients with acute cholecystitis while continuing APT. However, in case of severe local inflammation, there is a greater risk for massive hemorrhage.


2008 ◽  
Vol 86 (Supplement) ◽  
pp. 137-138
Author(s):  
M Marvin ◽  
M Eng ◽  
R Kadiyala ◽  
R Ouseph ◽  
R Nagubandi ◽  
...  

2020 ◽  
Author(s):  
Fumihiro Kawano ◽  
Ryuji Yoshioka ◽  
Yu Gyoda ◽  
Hirofumi Ichida ◽  
Tomoya Mizuno ◽  
...  

Abstract Background: Percutaneous transhepatic gallbladder drainage (PTGBD) is indicated for patients with acute cholecystitis (AC) who are not indicated for urgent surgery, but external tubes reduce quality of life (QOL) while waiting for elective surgery. The objective of the present study was to investigate the feasibility of laparoscopic cholecystectomy after endoscopic trans-papillary gallbladder stenting (ETGBS) comparing with after PTGBD.Methods: Intraoperative and postoperative outcomes of patients with ETGBS and PTGBD were retrospectively compared.Results: Eighteen ETGBS and ten PTGBD patients were compared. Differences in the duration of ETGBS and PTGBD [median 209 minutes (range, 107–357) and median 161 minutes (range, 130–273), respectively, P = 0.10], median blood loss [ETGBS 2 (range, 2–180 ml) and PTGBD 24 (range, 2–100 ml), P = 0.89], switch to laparotomy (ETGBS 11% and PTGBD 20%, P = 0.52), and median postoperative hospital stay [ETGBS 8 (range, 4–24 days) and ETGBS 8 (range 4–16 days), P = 0.99]. Thickening of the cystic duct that occurred in 60% of the ETGBS patients and none of the PTGBD patients (P = 0.005) interfered with closure of the duct by clipping. No obstruction occurred in ETGBS patients.Conclusion: ETGBS did not make laparoscopic cholecystectomy less feasible than after PTGBD.


Author(s):  
Sun Young Choi ◽  
Moo Hyun Kim ◽  
Young-Rak Cho ◽  
Jong Sung Park ◽  
Kwang Min Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document